Latest Period
Q4 2025
Security Snapshot
OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) Institutional Ownership
CUSIP: 68764Y207
13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025
Institutions Reporting
24
Shares (Excl. Options)
1,775,269
Price
$1.40
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- OSTX on NYSE
- Shares outstanding
- 31,500,824
- Price per share
- $1.52
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,775,269
- Total reported value
- $2,485,357
- % of total 13F portfolios
- 0%
- Share change
- +222,268
- Value change
- +$236,334
- Number of holders
- 24
- Price from insider filings
- $1.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- OSTX - OS Therapies Inc - Common Stock, par value $0.001 per share is tracked under CUSIP 68764Y207.
- 24 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 25 to 24 between Q3 2025 and Q4 2025.
- Reported value moved from $3,065,164 to $2,485,357.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 68764Y207?
CUSIP 68764Y207 identifies OSTX - OS Therapies Inc - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68764Y207:
Significant Owners of OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SATTERFIELD THOMAS A JR | 9.4% | +58% | $5,296,658 | +$3,141,967 | 3,115,681 | +146% | Thomas A. Satterfield, Jr. | 30 Jun 2025 |
| Auerbach Shalom | 8.5% | -14% | $4,899,953 | -$18,300 | 2,677,570 | -0.37% | Shalom Auerbach | 29 Jul 2025 |
| Ayala Pharmaceuticals, Inc. | 10% | $4,328,430 | 2,164,215 | AYALA PHARMACEUTICALS, INC. | 09 Apr 2025 |
As of 31 Dec 2025, 24 institutional investors reported holding 1,775,269 shares of OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX). This represents 5.6% of the company’s total 31,500,824 outstanding shares.
Institutional Holders of OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,775,269 | $2,485,357 | +$236,334 | $1.40 | 24 |
| 2025 Q3 | 1,563,221 | $3,065,164 | +$1,884,295 | $1.96 | 25 |
| 2025 Q2 | 603,727 | $1,134,576 | +$402,668 | $1.88 | 13 |
| 2025 Q1 | 389,286 | $599,294 | +$293,725 | $1.54 | 6 |
| 2024 Q4 | 145,004 | $620,617 | +$9,243 | $4.28 | 5 |
| 2024 Q3 | 160,043 | $447,782 | +$447,782 | $2.80 | 7 |